Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2021

06.01.2021 | Original Article

Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease

verfasst von: Harpal S. Dhaliwal, Ripudaman Singh, Abin M. Abraham, Rajan Sharma, N. K. Goyal, Rajat Soloman, Pankaj Bansal, Amandeep Goyal

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease of immense public health relevance. Understanding illness perceptions in the NAFLD population will provide sound scientific evidence for planning high-quality patient-centered care and implementing effective interventions. The Brief Illness Perception Questionnaire (BIPQ) is a robust psychometric tool to systematically assess the dimensions of illness perceptions in various chronic ailments.

Methods

In a cross-sectional study enrolling patients with newly diagnosed NAFLD, the sociodemographic, anthropometric, biochemical, and radiological determinants of enhanced illness perceptions (measured by the BIPQ score) were investigated using univariate and multivariable binary logistic regression analyses. Finally, the association between individual domains of the BIPQ and willingness to participate in comprehensive medical management was explored.

Results

In total, 264 patients (mean age 53 ± 11.9 years, 59.8% males) were enrolled in the final analysis. The mean and median BIPQ scores in the study population were 30.3 ± 12.8 and 31.0 (IQR, 22.0–40.0), respectively. The variables having a significant independent association with heightened perceptions (BIPQ > 31) were family history of liver disease (aOR, 5.93; 95% CI, 1.42–24.74), obesity (aOR, 3.33; 95% CI, 1.57–7.05), diabetes mellitus (aOR, 2.35; 95% CI, 1.01–5.49), and transaminitis (aOR, 2.85; 95% CI, 1.42–5.69). Patients with a higher level of illness perceptions (31.6 ± 12.9 vs 27.8 ± 12.3, p = 0.022) were more likely to express a willingness to participate in the comprehensive management plan, with 3 of the 8 domains (consequence, identity, and treatment control) mainly affecting willingness.

Conclusion

A family history of liver disease, obesity, diabetes, and transaminitis were independently associated with increased illness perceptions. A belief in serious consequences, a strong illness identity, and higher perceived treatment control were significantly associated with the willingness to undergo comprehensive care for NAFLD.
Literatur
1.
Zurück zum Zitat Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419.PubMed Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419.PubMed
2.
Zurück zum Zitat Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99-s112.PubMed Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99-s112.PubMed
3.
Zurück zum Zitat Younossi ZM, Koenig AB, Abdelatif D et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.PubMed Younossi ZM, Koenig AB, Abdelatif D et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.PubMed
4.
Zurück zum Zitat Targher G, Byrne CD, Lonardo A et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589–600.PubMed Targher G, Byrne CD, Lonardo A et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65:589–600.PubMed
5.
Zurück zum Zitat VanWagner LB, Rinella ME. Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr Hepatol Rep. 2016;15:75–85.PubMedPubMedCentral VanWagner LB, Rinella ME. Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr Hepatol Rep. 2016;15:75–85.PubMedPubMedCentral
6.
Zurück zum Zitat Sanyal AJ, Chalasani N, Kowdley KV et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–1685.PubMedPubMedCentral Sanyal AJ, Chalasani N, Kowdley KV et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–1685.PubMedPubMedCentral
7.
Zurück zum Zitat Armstrong MJ, Gaunt P, Aithal GP et al. Liraglutide safety and efficacy in patients with nonalcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387:679–690.PubMed Armstrong MJ, Gaunt P, Aithal GP et al. Liraglutide safety and efficacy in patients with nonalcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet. 2016;387:679–690.PubMed
8.
Zurück zum Zitat Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367–78.e5; quiz e14–5. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367–78.e5; quiz e14–5.
9.
Zurück zum Zitat Abd El-Kader SM, El-Den Ashmawy EM. Nonalcoholic fatty liver disease: the diagnosis and management. World J Hepatol. 2015;7:846–858.PubMedPubMedCentral Abd El-Kader SM, El-Den Ashmawy EM. Nonalcoholic fatty liver disease: the diagnosis and management. World J Hepatol. 2015;7:846–858.PubMedPubMedCentral
10.
Zurück zum Zitat Broadbent E, Petrie KJ, Main J et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–637.PubMed Broadbent E, Petrie KJ, Main J et al. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631–637.PubMed
11.
Zurück zum Zitat Broadbent E, Wilkes C, Koschwanez H et al. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol Health. 2015;30:1361–1385.PubMed Broadbent E, Wilkes C, Koschwanez H et al. A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol Health. 2015;30:1361–1385.PubMed
12.
Zurück zum Zitat Dudala S. Updated Kuppuswamy’s socioeconomic scale for 2012. J Dr NTR Univ Health Sci. 2013;2:201–202. Dudala S. Updated Kuppuswamy’s socioeconomic scale for 2012. J Dr NTR Univ Health Sci. 2013;2:201–202.
13.
Zurück zum Zitat Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285:2486–2497. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama. 2001;285:2486–2497.
14.
Zurück zum Zitat Misra A, Chowbey P, Makkar BM et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–170.PubMed Misra A, Chowbey P, Makkar BM et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163–170.PubMed
15.
Zurück zum Zitat Nampoothiri RV, Duseja A, Rathi M et al. Renal dysfunction in patients with nonalcoholic fatty liver disease is related to the presence of diabetes mellitus and severity of liver disease. J Clin Exp Hepatol. 2019;9:22–28.PubMed Nampoothiri RV, Duseja A, Rathi M et al. Renal dysfunction in patients with nonalcoholic fatty liver disease is related to the presence of diabetes mellitus and severity of liver disease. J Clin Exp Hepatol. 2019;9:22–28.PubMed
16.
Zurück zum Zitat Peduzzi P, Concato J, Kemper E et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–1379.PubMed Peduzzi P, Concato J, Kemper E et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–1379.PubMed
18.
Zurück zum Zitat David K, Kowdley KV, Unalp A et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:1904–1912.PubMed David K, Kowdley KV, Unalp A et al. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:1904–1912.PubMed
19.
Zurück zum Zitat Dan AA, Kallman JB, Wheeler A et al. Health-related quality of life in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26:815–820.PubMed Dan AA, Kallman JB, Wheeler A et al. Health-related quality of life in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26:815–820.PubMed
20.
Zurück zum Zitat Younossi ZM, Blissett D, Blissett R et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64:1577–1586. Younossi ZM, Blissett D, Blissett R et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64:1577–1586.
21.
Zurück zum Zitat Estes C, Razavi H, Loomba R et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–133.PubMed Estes C, Razavi H, Loomba R et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–133.PubMed
22.
Zurück zum Zitat Pakhomov SV, Jacobsen SJ, Chute CG et al. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14:530–539.PubMedPubMedCentral Pakhomov SV, Jacobsen SJ, Chute CG et al. Agreement between patient-reported symptoms and their documentation in the medical record. Am J Manag Care. 2008;14:530–539.PubMedPubMedCentral
23.
Zurück zum Zitat Huber Y, Boyle M, Hallsworth K et al. Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation. Clin Gastroenterol Hepatol. 2019;17:2085–2092.e1. Huber Y, Boyle M, Hallsworth K et al. Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation. Clin Gastroenterol Hepatol. 2019;17:2085–2092.e1.
24.
Zurück zum Zitat Alt Y, Grimm A, Schlegel L et al. The impact of liver cell injury on health-related quality of life in patients with chronic liver disease. PLoS ONE. 2016;11:e0151200.PubMedPubMedCentral Alt Y, Grimm A, Schlegel L et al. The impact of liver cell injury on health-related quality of life in patients with chronic liver disease. PLoS ONE. 2016;11:e0151200.PubMedPubMedCentral
25.
Zurück zum Zitat Tiemensma J, Kaptein AA, Pereira AM et al. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur J Endocrinol. 2011;165:527–535.PubMed Tiemensma J, Kaptein AA, Pereira AM et al. Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing’s syndrome. Eur J Endocrinol. 2011;165:527–535.PubMed
26.
Zurück zum Zitat Wu H, Zhao X, Fritzsche K et al. Negative illness perceptions associated with low mental and physical health status in general hospital outpatients in China. Psychol Health Med. 2014;19:273–285.PubMed Wu H, Zhao X, Fritzsche K et al. Negative illness perceptions associated with low mental and physical health status in general hospital outpatients in China. Psychol Health Med. 2014;19:273–285.PubMed
27.
Zurück zum Zitat Zelber-Sagi S, Bord S, Dror-Lavi G et al. Role of illness perception and self-efficacy in lifestyle modification among nonalcoholic fatty liver disease patients. World J Gastroenterol. 2017;23:1881–1890.PubMedPubMedCentral Zelber-Sagi S, Bord S, Dror-Lavi G et al. Role of illness perception and self-efficacy in lifestyle modification among nonalcoholic fatty liver disease patients. World J Gastroenterol. 2017;23:1881–1890.PubMedPubMedCentral
28.
Zurück zum Zitat Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol. 1990;9:632–646.PubMed Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol. 1990;9:632–646.PubMed
29.
Zurück zum Zitat Kroll T, Kehn M, Ho P-S et al. The SCI Exercise Self-Efficacy Scale (ESES): development and psychometric properties. Int J Behav Nutr Phys Act. 2007;4:34–34.PubMedPubMedCentral Kroll T, Kehn M, Ho P-S et al. The SCI Exercise Self-Efficacy Scale (ESES): development and psychometric properties. Int J Behav Nutr Phys Act. 2007;4:34–34.PubMedPubMedCentral
30.
Zurück zum Zitat Mlynarsky L, Schlesinger D, Lotan R et al. Nonalcoholic fatty liver disease is not associated with a lower health perception. World J Gastroenterol. 2016;22:4362–4372.PubMedPubMedCentral Mlynarsky L, Schlesinger D, Lotan R et al. Nonalcoholic fatty liver disease is not associated with a lower health perception. World J Gastroenterol. 2016;22:4362–4372.PubMedPubMedCentral
31.
Zurück zum Zitat Frostholm L, Fink P, Christensen KS et al. The patients’ illness perceptions and the use of primary health care. Psychosom Med. 2005;67:997–1005.PubMed Frostholm L, Fink P, Christensen KS et al. The patients’ illness perceptions and the use of primary health care. Psychosom Med. 2005;67:997–1005.PubMed
32.
Zurück zum Zitat Jackson J, Fiddler M, Kapur N et al. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res. 2006;60:357–363.PubMed Jackson J, Fiddler M, Kapur N et al. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics. J Psychosom Res. 2006;60:357–363.PubMed
33.
Zurück zum Zitat Scharloo M, Kaptein AA, Weinman J et al. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol. 2000;142:899–907.PubMed Scharloo M, Kaptein AA, Weinman J et al. Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol. 2000;142:899–907.PubMed
34.
Zurück zum Zitat Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989;39:495–498.PubMedPubMedCentral Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract. 1989;39:495–498.PubMedPubMedCentral
35.
Zurück zum Zitat Scharloo M, Kaptein AA, Weinman J et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998;44:573–585.PubMed Scharloo M, Kaptein AA, Weinman J et al. Illness perceptions, coping and functioning in patients with rheumatoid arthritis, chronic obstructive pulmonary disease and psoriasis. J Psychosom Res. 1998;44:573–585.PubMed
36.
Zurück zum Zitat Petrie KJ, Weinman J, Sharpe N et al. Role of patients’ view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. BMJ. 1996;312:1191–1194.PubMedPubMedCentral Petrie KJ, Weinman J, Sharpe N et al. Role of patients’ view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. BMJ. 1996;312:1191–1194.PubMedPubMedCentral
37.
Zurück zum Zitat Lerdal A, Hofoss D, Gay CL et al. Perception of illness among patients with heart failure is related to their general health independently of their mood and functional capacity. J Patient Rep Outcomes. 2019;3:55.PubMedPubMedCentral Lerdal A, Hofoss D, Gay CL et al. Perception of illness among patients with heart failure is related to their general health independently of their mood and functional capacity. J Patient Rep Outcomes. 2019;3:55.PubMedPubMedCentral
38.
Zurück zum Zitat Frith J, Day CP, Robinson L et al. Potential strategies to improve uptake of exercise interventions in nonalcoholic fatty liver disease. J Hepatol. 2010;52:112–116.PubMed Frith J, Day CP, Robinson L et al. Potential strategies to improve uptake of exercise interventions in nonalcoholic fatty liver disease. J Hepatol. 2010;52:112–116.PubMed
39.
Zurück zum Zitat Centis E, Moscatiello S, Bugianesi E et al. Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol. 2013;58:771–777.PubMed Centis E, Moscatiello S, Bugianesi E et al. Stage of change and motivation to healthier lifestyle in nonalcoholic fatty liver disease. J Hepatol. 2013;58:771–777.PubMed
40.
Zurück zum Zitat Petrie KJ, Cameron LD, Ellis CJ et al. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med. 2002;64:580–586.PubMed Petrie KJ, Cameron LD, Ellis CJ et al. Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med. 2002;64:580–586.PubMed
41.
Zurück zum Zitat Petrie KJ, Perry K, Broadbent E et al. A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17:74–84.PubMed Petrie KJ, Perry K, Broadbent E et al. A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17:74–84.PubMed
42.
Zurück zum Zitat Keogh KM, Smith SM, White P et al. Psychological family intervention for poorly controlled type 2 diabetes. Am J Manag Care. 2011;17:105–113.PubMed Keogh KM, Smith SM, White P et al. Psychological family intervention for poorly controlled type 2 diabetes. Am J Manag Care. 2011;17:105–113.PubMed
43.
Zurück zum Zitat Davies MJ, Heller S, Skinner TC et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336:491–495.PubMedPubMedCentral Davies MJ, Heller S, Skinner TC et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ. 2008;336:491–495.PubMedPubMedCentral
44.
Zurück zum Zitat Cunningham MA, Swanson V, O’Carroll RE et al. Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. Br J Surg. 2012;99:49–56.PubMed Cunningham MA, Swanson V, O’Carroll RE et al. Randomized clinical trial of a brief psychological intervention to increase walking in patients with intermittent claudication. Br J Surg. 2012;99:49–56.PubMed
45.
Zurück zum Zitat Sararoudi RB, Motmaen M, Maracy MR et al. Efficacy of illness perception focused intervention on quality of life, anxiety, and depression in patients with myocardial infarction. J Res Med Sci. 2016;21:125.PubMedPubMedCentral Sararoudi RB, Motmaen M, Maracy MR et al. Efficacy of illness perception focused intervention on quality of life, anxiety, and depression in patients with myocardial infarction. J Res Med Sci. 2016;21:125.PubMedPubMedCentral
46.
Zurück zum Zitat Williams CD, Stengel J, Asike MI et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–131.PubMed Williams CD, Stengel J, Asike MI et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–131.PubMed
47.
Zurück zum Zitat Younossi ZM, Gramlich T, Matteoni CA et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2004;2:262–265.PubMed Younossi ZM, Gramlich T, Matteoni CA et al. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol. 2004;2:262–265.PubMed
48.
Zurück zum Zitat Younossi ZM, Stepanova M, Rafiq N et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53:1874–1882.PubMed Younossi ZM, Stepanova M, Rafiq N et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53:1874–1882.PubMed
49.
Zurück zum Zitat Younossi ZM, Otgonsuren M, Venkatesan C et al. In patients with nonalcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism. 2013;62:352–360.PubMed Younossi ZM, Otgonsuren M, Venkatesan C et al. In patients with nonalcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism. 2013;62:352–360.PubMed
50.
Zurück zum Zitat Dulai PS, Singh S, Patel J et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557–1565.PubMed Dulai PS, Singh S, Patel J et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557–1565.PubMed
51.
Zurück zum Zitat Angulo P. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? Hepatology. 2010;51:373–375.PubMed Angulo P. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? Hepatology. 2010;51:373–375.PubMed
52.
Zurück zum Zitat Angulo P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology. 2011;53:1792–1794.PubMed Angulo P. Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts. Hepatology. 2011;53:1792–1794.PubMed
53.
Zurück zum Zitat Taylor R, Brown JS, Weinman J. A comparison of the illness perceptions of North Indian and white British women. J Ment Health. 2013;22:22–32.PubMed Taylor R, Brown JS, Weinman J. A comparison of the illness perceptions of North Indian and white British women. J Ment Health. 2013;22:22–32.PubMed
Metadaten
Titel
Perception of Illness and Its Association with Treatment Willingness in Patients with Newly Diagnosed Nonalcoholic Fatty Liver Disease
verfasst von
Harpal S. Dhaliwal
Ripudaman Singh
Abin M. Abraham
Rajan Sharma
N. K. Goyal
Rajat Soloman
Pankaj Bansal
Amandeep Goyal
Publikationsdatum
06.01.2021
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06794-2

Weitere Artikel der Ausgabe 12/2021

Digestive Diseases and Sciences 12/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.